Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	14.50	47.18	41.21
Graham Fair Price	8.39	20.94	19.32
PEG	-36.09	0.95	-1.48
Price/Book	-0.25	3.92	3.93
Price/Cash Flow	28.96	49.26	38.20
Prices/Earnings	-10.81	13.81	15.48
Price/Sales	1.16	7.26	7.18
Price/FCF	28.96	49.26	38.20
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-4.01	0.33	0.34
Operating Margin	10.61	0.17	0.16
ROA	13.89	0.02	0.02
ROE	0.06	0.07	11.84
ROIC	0.03	0.03	10.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.01	0.03	-63.96
Dividends QOQ	< 0.005	< 0.005	-66.40
EBIT QOQ	-0.13	0.10	-23.34
EPS QOQ	-0.10	0.15	39.56
FCF QOQ	3.08	-0.22	-92.81
Revenue QOQ	0.05	< 0.005	-83.65
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	57.79	48.14	-16.69
Days Sales Outstanding (DSO)	30.80	31.26	1.49
Inventory Turnover	1.56	1.87	20.03
Debt/Capitalization	0.57	0.57	-0.73
Quick Ratio	0.30	0.33	12.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	16.17	16.57	2.49
Cash	1.02	1.03	0.97
Capex	-0.26	-0.34	-28.30
Free Cash Flow	1.66	1.32	-20.73
Revenue	8.86	8.95	1.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.64	0.66	3.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.15	11.50	13.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating